We are live on ! Find out more
MYIA

Mount Yale Investment Advisors Portfolio holdings

AUM $4.31B
1-Year Est. Return 21.13%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+21.13%
3 Year Est. Return
+69.37%
5 Year Est. Return
+92.43%
10 Year Est. Return
–
AUM
$920M
AUM Growth
-$42.1M
Cap. Flow
+$13.3M
Cap. Flow %
1.45%
Top 10 Hldgs %
29.38%
Holding
508
New
52
Increased
220
Reduced
173
Closed
46

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$6.78M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$2.73M
3
FERG icon
Ferguson
FERG
+$2.29M
4
NVO
Novo Nordisk
NVO
+$2.22M
5
IBM icon
IBM
IBM
+$1.53M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.57M
2
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$5.41M
3
IVE icon
iShares S&P 500 Value ETF
IVE
+$3.3M
4
IVW icon
iShares S&P 500 Growth ETF
IVW
+$2.81M
5
TSM icon
TSMC
TSM
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 31.63%
2 Healthcare 10.88%
3 Financials 9.7%
4 Communication Services 7.54%
5 Consumer Discretionary 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USFD icon
376
US Foods
USFD
$23.9B
$287K 0.03%
+7,632
New +$278K
SGFY
377
DELISTED
Signify Health, Inc.
SGFY
$286K 0.03%
15,764
– –
IWD icon
378
iShares Russell 1000 Value ETF
IWD
$84.2B
$285K 0.03%
1,715
+194
+13% +$31.9K
SPXC icon
379
SPX Corp
SPXC
$10.6B
$284K 0.03%
5,749
+987
+21% +$51.1K
MGPI icon
380
MGP Ingredients
MGPI
$381M
$280K 0.03%
3,267
-140
-4% -$11.3K
ACHC icon
381
Acadia Healthcare
ACHC
$2.96B
$279K 0.03%
4,254
-680
-14% -$39.5K
PCRX icon
382
Pacira BioSciences
PCRX
$974M
$278K 0.03%
+3,639
New +$243K
WK icon
383
Workiva
WK
$3.66B
$277K 0.03%
2,351
+552
+31% +$61K
KLAC icon
384
KLA
KLAC
$252B
$276K 0.03%
7,550
+60
+0.8% +$2.24K
OMCL icon
385
Omnicell
OMCL
$1.7B
$276K 0.03%
2,131
+574
+37% +$82.7K
QRVO icon
386
Qorvo
QRVO
$8.56B
$274K 0.03%
2,206
-66
-3% -$8.93K
EGP icon
387
EastGroup Properties
EGP
$10.9B
$273K 0.03%
1,344
-8
-0.6% -$1.58K
MHK icon
388
Mohawk Industries
MHK
$9.19B
$273K 0.03%
2,198
+30
+1% +$4.5K
MTDR icon
389
Matador Resources
MTDR
$6.46B
$273K 0.03%
+5,145
New +$243K
THC icon
390
Tenet Healthcare
THC
$20.9B
$273K 0.03%
3,174
-928
-23% -$76.2K
TXRH icon
391
Texas Roadhouse
TXRH
$13.6B
$273K 0.03%
+3,261
New +$279K
SHOO icon
392
Steven Madden
SHOO
$3.58B
$272K 0.03%
7,047
+1
+0% +$41
SR icon
393
Spire
SR
$4.79B
$272K 0.03%
3,793
+146
+4% +$9.68K
OPCH icon
394
Option Care Health
OPCH
$3.67B
$271K 0.03%
9,500
-174
-2% -$4.37K
LSCC icon
395
Lattice Semiconductor
LSCC
$18.2B
$270K 0.03%
4,429
-246
-5% -$14.8K
INMD icon
396
InMode
INMD
$873M
$269K 0.03%
7,276
+4,150
+133% +$186K
SNCY
397
DELISTED
Sun Country Airlines
SNCY
$267K 0.03%
+10,187
New +$266K
AXTA icon
398
Axalta
AXTA
$8.01B
$266K 0.03%
10,840
+393
+4% +$11K
CALY
399
Callaway Golf Company
CALY
$3.04B
$265K 0.03%
+11,321
New +$275K
GEN icon
400
Gen Digital
GEN
$17.5B
$262K 0.03%
+9,863
New +$271K
14 15
16
17 18

Similar funds

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return

Mount Yale Investment Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Mount Yale Investment Advisors held 508 positions worth $920M, down 4.4% from $962M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Mount Yale Investment Advisors's Q1 2022 filing shows 52 new, 220 increased, 173 reduced and 46 closed positions. Its largest new stake was Gilead Sciences: 105,999 shares worth $6.3M. The largest sale was Bristol-Myers Squibb, an estimated $6.57M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • Mount Yale Investment Advisors's largest Q1 2022 buy was Gilead Sciences: 105,999 shares worth $6.3M.
  • Mount Yale Investment Advisors added most to iShares Core S&P Total US Stock Market ETF in Q1 2022, an estimated $2.73M increase.
  • Mount Yale Investment Advisors's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $6.57M.
  • Mount Yale Investment Advisors fully exited iShares S&P 500 Growth ETF in Q1 2022, selling an estimated $2.81M.
  • Mount Yale Investment Advisors's ten largest holdings make up 29% of its $920M portfolio in Q1 2022.
  • Mount Yale Investment Advisors opened 52 new positions and closed 46 in Q1 2022.
  • Mount Yale Investment Advisors's portfolio value fell 4.4% quarter-over-quarter to $920M.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2022, filed 3 May 2022.